Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of (R)-Miconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 12/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.98 |
| ▸ | LMNA | P02545 | 5/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.98 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.98 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.98 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.98 |
| ▸ | PGR | P06401 | 4/20 | 0.98 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.98 |
| ▸ | DRD2 | P14416 | 4/20 | 0.98 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.98 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.98 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.98 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.98 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Miconazole SCHEMBL9479808 | 1.00 | IDO1 (0.98) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL9479815 | 1.00 | IDO1 (0.98) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL3366 | 1.00 | IDO1 (0.98) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL13934598 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL2866 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| (R)-Miconazole SCHEMBL2867 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| (R)-Miconazole SCHEMBL30594078 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL9662051 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL7647866 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 | |
| Miconazole SCHEMBL64342 | 0.99 | IDO1 (1.00) | IDO1CYP2C9CYP3A4LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117126810-A | Tumor infiltrating lymphocyte culture method | 上海君赛生物科技有限公司 | 2023-11-28 | — | — | CN | claimed |
| WO-2020068665-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2020-04-02 | — | — | WO | claimed |
| US-10293033-B2 | Proteolytic extract from bromelain for the treatment of connective tissue disorders | MEDIWOUND LTD. (IL) | 2019-05-21 | — | — | US | claimed |
| EP-2734216-B1 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | MEDIWOUND LTD (IL) | 2018-07-25 | — | — | EP | claimed |
| US-20170049865-A1 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | MEDIWOUND LTD. (IL) | 2017-02-23 | — | — | US | claimed |
| US-9511126-B2 | Proteolytic extract from bromelain for the treatment of connective tissue disorders | MEDIWOUND LTD. (IL) | 2016-12-06 | — | — | US | claimed |
| US-9314431-B2 | Solubilized benzoyl small molecule | TRANSDERMAL CORP (US) | 2016-04-19 | — | — | US | claimed |
| US-9308268-B2 | Solubilized benzoyl peroxyde acne | TRANSDERMAL CORP (US) | 2016-04-12 | — | — | US | claimed |
| US-20140154229-A1 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | MEDIWOUND LTD. (IL) | 2014-06-05 | — | — | US | claimed |
| EP-2734216-A1 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | Mediwound, Ltd. (IL) | 2014-05-28 | — | — | EP | claimed |
| WO-2013011514-A1 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | MEDIWOUND LTD. (IL) | 2013-01-24 | — | — | WO | claimed |
| US-20110033402-A1 | Solubilized benzoyl small molecule | TRANSDERMAL CORP. | 2011-02-10 | — | — | US | claimed |
| US-20110027382-A1 | Solubilized benzoyl peroxyde acne | TRANSDERMAL CORP. | 2011-02-03 | — | — | US | claimed |
| US-20090304820-A1 | SOLUBILIZED BENZOYL PEROXIDE TOPICAL DRUG FORMULATION FOR THE TREATMENT OF ACNE | TRANSDERMAL CORP. | 2009-12-10 | — | — | US | claimed |
| EP-1848541-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | Pharmalight Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2007117352-A2 | TOPICAL THERAPEUTIC DELIVERY SYSTEM | MURAD HOWARD (US) | 2007-10-18 | — | — | WO | claimed |
| WO-2007092085-A2 | FRAGRANCED THERAPEUTIC DELIVERY SYSTEM | MURAD HOWARD (US) | 2007-08-16 | — | — | WO | claimed |
| WO-2006082588-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | PHARMALIGHT INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-5948416-A | LEAVE ON SKIN CARE COMPOSITION; HYDROPHOBIC STRUCTURING AGENT; HYDROPHILIC CATIONIC SURFACTANT; ACTIVE COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-07 | — | — | US | claimed |
| US-5780049-A | Enhanced skin penetration system for improved topical delivery of drugs | RICHARDSON-VICKS INC. (US) | 1998-07-14 | — | — | US | claimed |